Y A Aken'Ova

816 total citations
28 papers, 423 citations indexed

About

Y A Aken'Ova is a scholar working on Genetics, Hematology and Emergency Medicine. According to data from OpenAlex, Y A Aken'Ova has authored 28 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 10 papers in Hematology and 7 papers in Emergency Medicine. Recurrent topics in Y A Aken'Ova's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (7 papers) and Hematological disorders and diagnostics (4 papers). Y A Aken'Ova is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (7 papers) and Hematological disorders and diagnostics (4 papers). Y A Aken'Ova collaborates with scholars based in Nigeria, United Kingdom and United States. Y A Aken'Ova's co-authors include John Ayodele Olaniyi, Iheanyi Okpala, L S Salimonu, Titilola S. Akingbola, E. E. U. Akang, Isaac F. Adewole, Samuel Anu Olowookere, Akinola Ayoola Fatiregun, Kofi A. Anie and J.A. Morris and has published in prestigious journals such as British Journal of Haematology, Journal of Internal Medicine and Transactions of the Royal Society of Tropical Medicine and Hygiene.

In The Last Decade

Y A Aken'Ova

28 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y A Aken'Ova Nigeria 11 186 175 64 62 57 28 423
Ruth Spearing New Zealand 15 229 1.2× 328 1.9× 66 1.0× 23 0.4× 84 1.5× 43 727
Lawrence M. Opas United States 10 246 1.3× 210 1.2× 42 0.7× 60 1.0× 53 0.9× 17 519
Zehra Fadoo Pakistan 13 76 0.4× 152 0.9× 33 0.5× 33 0.5× 102 1.8× 50 391
Şebnem Yılmaz Türkiye 13 47 0.3× 193 1.1× 105 1.6× 43 0.7× 70 1.2× 56 461
Adalet Meral Güneş Türkiye 15 124 0.7× 231 1.3× 42 0.7× 25 0.4× 140 2.5× 52 545
Zegeye Getaneh Ethiopia 12 55 0.3× 123 0.7× 91 1.4× 27 0.4× 30 0.5× 28 440
Laurence Rozen Belgium 13 303 1.6× 432 2.5× 148 2.3× 50 0.8× 26 0.5× 40 647
Emmanuel Hatzipantelis Greece 16 92 0.5× 122 0.7× 30 0.5× 60 1.0× 233 4.1× 65 649
Andrea Tendas Italy 15 57 0.3× 189 1.1× 32 0.5× 48 0.8× 132 2.3× 56 584
Nikita Mody‐Patel United States 10 478 2.6× 480 2.7× 26 0.4× 20 0.3× 59 1.0× 22 673

Countries citing papers authored by Y A Aken'Ova

Since Specialization
Citations

This map shows the geographic impact of Y A Aken'Ova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y A Aken'Ova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y A Aken'Ova more than expected).

Fields of papers citing papers by Y A Aken'Ova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y A Aken'Ova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y A Aken'Ova. The network helps show where Y A Aken'Ova may publish in the future.

Co-authorship network of co-authors of Y A Aken'Ova

This figure shows the co-authorship network connecting the top 25 collaborators of Y A Aken'Ova. A scholar is included among the top collaborators of Y A Aken'Ova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y A Aken'Ova. Y A Aken'Ova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aken'Ova, Y A, et al.. (2020). Homocysteine Levels in Patients with Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome in Ibadan. International Journal Of Medical Science And Clinical Invention. 7(2). 4739–4745. 1 indexed citations
2.
3.
Ngoma, Twalib, Melissa Adde, Muheez A. Durosinmi, et al.. (2012). Treatment of Burkitt lymphoma in equatorial Africa using a simple three‐drug combination followed by a salvage regimen for patients with persistent or recurrent disease. British Journal of Haematology. 158(6). 749–762. 35 indexed citations
4.
Akingbola, Titilola S., et al.. (2011). Abdominal pain in adult sickle cell disease patients: a nigerian experience.. PubMed. 9(2). 100–4. 9 indexed citations
5.
Olowookere, Samuel Anu, et al.. (2011). Reducing Waiting Time at a Nigerian HIV Treatment Clinic. Journal of the International Association of Physicians in AIDS Care. 11(3). 188–191. 19 indexed citations
6.
Olujohungbe, Adebayo, Adebanji Adeyoju, Anne Yardumian, et al.. (2010). A Prospective Diary Study of Stuttering Priapism in Adolescents and Young Men With Sickle Cell Anemia: Report of an International Randomized Control Trial--The Priapism in Sickle Cell Study. Journal of Andrology. 32(4). 375–382. 46 indexed citations
7.
Odaibo, Georgina N., et al.. (2008). Detection of HIV antigen and cDNA among antibody-negative blood samples in Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 102(3). 284–287. 10 indexed citations
8.
Ogbole, Godwin, et al.. (2008). Abdominal ultrasonography in HIV/AIDS patients in southwestern Nigeria. BMC Medical Imaging. 8(1). 5–5. 24 indexed citations
9.
Akang, E. E. U., et al.. (2006). Prevalence of venous thromboembolism at post-mortem in an African population: a cause for concern.. PubMed. 35(3). 345–8. 19 indexed citations
10.
Akingbola, Titilola S., et al.. (2006). Haematological profile of healthy pregnant women in Ibadan, South-western Nigeria. Journal of Obstetrics and Gynaecology. 26(8). 763–769. 38 indexed citations
11.
Aken'Ova, Y A, et al.. (2003). Waldenstrom's macrogloblinaemia: modified plasmapheresis as treatment option in a Nigeria setting.. PubMed. 11(4). 190–2. 4 indexed citations
12.
Kotila, Taiwo R., et al.. (2001). Hodgkin's disease after treatment for Burkitt's lymphoma: case report. East African Medical Journal. 78(6). 334–6. 3 indexed citations
13.
Akinola, N O, et al.. (2000). Acceptability of prenatal diagnosis of sickle cell anaemia by a sample of the Nigerian population.. PubMed. 26(1-2). 55–8. 9 indexed citations
14.
Aken'Ova, Y A, et al.. (1996). Neurological manifestations of chronic myelogenous leukaemia.. PubMed. 25(4). 397–8. 3 indexed citations
15.
Aken'Ova, Y A, et al.. (1996). Bacterial causes of acute osteomyelitis in sickle cell anaemia: changing infection profile.. PubMed. 14(4). 255–8. 11 indexed citations
16.
Aken'Ova, Y A, et al.. (1993). Hepatobiliary changes in Nigerians with sickle cell anaemia. Annals of Tropical Medicine and Parasitology. 87(6). 603–606. 9 indexed citations
17.
Aken'Ova, Y A, et al.. (1993). Acute phase reactants and severity of homozygous sickle cell disease. Journal of Internal Medicine. 233(6). 467–470. 67 indexed citations
18.
Aken'Ova, Y A, et al.. (1993). Serum immunoglobulin (G, A and M) classes and IgG subclasses in sickle cell anaemia. Apmis. 101(1-6). 353–357. 9 indexed citations
19.
Aken'Ova, Y A, et al.. (1992). Aplastic anaemia: a review of cases at the University College Hospital, Ibadan, Nigeria.. PubMed. 38(9). 362–7. 1 indexed citations
20.
Okpala, Iheanyi, et al.. (1989). Changing patterns of acute lymphoblastic leukaemia in Nigeria.. PubMed. 14(4). 301–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026